Evidence map›Paper›PMID 40863634›Full record

ReviewMarine drugs2025

Neoxanthin: A Promising Medicinal and Nutritional Carotenoid.

Jiarong Zhao, Gengjie Zhuang, Jinrong Zhang

Abstract readReview
In one paragraph

Review in Marine drugs, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jiarong ZhaoCollege of Food Sciences and Engineering, Ningbo University, Ningbo 315211, China.
Gengjie ZhuangSchool of Marine Sciences, Ningbo University, Ningbo 315211, China.
Jinrong ZhangCollege of Food Sciences and Engineering, Ningbo University, Ningbo 315211, China.ORCID 0000-0003-0774-8479

Funding

the Science and Technology Program of Zhejiang Province LGG22D060001, LTGC24D060001
6 · The paper itself

Abstract

Neoxanthin is a xanthophyll carotenoid with high-value nutritional functions for human health due to its anti-cancer, anti-oxidative, and anti-obesity activities. In this present work, we systematically reviewed the structure, source, and biosynthetic pathways of neoxanthin, and discussed the advantages and disadvantages of the prevailing extraction methods of neoxanthin. Meanwhile, this review described the latest research progress on the pharmacological activities of neoxanthin. Finally, we concluded with a discussion on the main challenges of neoxanthin production from microalgae, and proposed some future development prospects and potential solutions.

Indexed as

XanthophyllsAnimalsAntineoplastic AgentsAnti-Obesity AgentsAntioxidantsCarotenoidsHumansMicroalgaeAntineoplastic AgentsAnti-Obesity AgentsAntioxidantsCarotenoidsneoxanthinXanthophyllsbiosynthetic pathwaysextractionmicroalgaepharmacological activitiessource

Identifiers

PMID40863634
PMCPMC12387748

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.